GVR Report cover Clinical Decision Support Systems Market Size, Share & Trends Report

Clinical Decision Support Systems Market Size, Share & Trends Analysis Report By Product (Standalone CDSS, Integrated EHR with CDSS), By Application, By Delivery Mode, By Component, By Region, And Segment Forecasts, 2022 - 2030

  • Published Date: Apr 2022
  • Report ID: GVR-2-68038-339-3
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Data: 2017 - 2020

Report Overview

The global clinical decision support systems market size was valued at USD 4.48 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 10.4% from 2022 to 2030. The rising demand for quality care and integrated reliable technical solutions is one of the key trends escalating the market growth. Increasing adoption of information systems by hospitals and healthcare institutes and favorable initiatives taken by several governments worldwide are also stimulating the growth of the market. Clinical decision support systems are strictly regulated by authorities such as the FDA. Therefore, platforms introduced or in developmental phases are expected to fulfill relevant criteria set by the FDA and CE Mark. In addition, competitors have to take into account the non-violation of information technology and cyber laws to assure products’ integrity.

North America clinical decision support systems market size, by product, 2020 - 2030 (USD Billion)

CDSS vendors and organizations have undertaken initiatives to help curb the pandemic. CDSS has become a vital tool in the fight against COVID-19 as it showed how healthcare teams can stay on top of the latest COVID information and intelligence, helping advance the quality of the care they provide. The Infectious Diseases Society of America endorsed repeating a COVID-19 test in patients with a moderate to the high probability of COVID-19. However, there was little direction about what factors cause a patient to have a low or high probability of contracting the infection. A team of infectious disease specialists at Massachusetts General Hospital worked around the clock. Thus, dedicated efforts led to the development of a CDS tool called COvid Risk cALculator (CORAL). The tool is embedded within the EHR. This is expected to positively impact market growth. Moreover, in October 2020, CORAL, an outpatient version was introduced. CORAL remained exclusive as the only algorithm that has been combined into routine, prospective clinician workflow through an EHR CDSS.

Rapid advancements in the fields of biotechnology and bioinformatics are encouraging improvements and optimizations in data storage, management, and analytics platforms. The marketplace is anticipated to witness a large number of innovations following R&D projects backed up by large corporate investments. Integration of cloud computing and interoperability platforms in different systems will further promote smooth functioning and seamless data flow, thereby revving up the adoption of CDSS.

In recent years, there has been substantial growth in the number of hospitals and healthcare facilities adopting various types and levels of clinical decision support systems, indicating a significant potential for increased deployment shortly. In industrialized regions, demand for decision assistance based on factual evidence and real-time knowledge has increased at a quicker rate. CDSS makes physical order entry easier by allowing physicians to choose from a database of prescriptions. The growing number of patients attending clinics and hospitals has made it more difficult to keep track of and manage data for each one.

Over the past few years, the development of collaborations among CDSS providers and hospitals has witnessed a significant surge. Government recognition and initiatives to encourage the adoption of CDSS and EHR systems are estimated to further increase the demand. Integration with Electronic Health Records (EHR) improves the efficiency of clinical care by reducing the time to search for a patient’s history and clinical records. Furthermore, U.S. Government's Health and Medicare Acts have endorsed CDSS, financially rewarding CDS integration into EHRs (Electronic Health Records). In 2013, around 41% of U.S. hospitals having an EHR also had a CDSS, while 40.2% of U.S. hospitals had cutting-edge CDS capability in 2017. In addition, companies are involved in partnerships to develop and provide software updated with the latest information.

Clinical decision-making is a complicated task that requires a knowledgeable practitioner, a supportive environment, and reliable informational inputs. The difficulty faced in quality clinical decision-making by healthcare entities can be addressed with the implementation of CDSS as a supportive tool. The emergence of CDSS has been recognized as an important tool to overcome issues in delivering high-quality care to patients by improving and streamlining the quality of healthcare delivery.

Product Insights

Standalone CDSS held the largest revenue share of over 30.0% in 2021 as it is widely adopted due to its low cost and simplicity. Ease to use in hospitals and clinical settings has contributed to its growth. The standalone segment will continue to dominate the market throughout the forecast period. CDSS products are available either in standalone or in integration with EHR or CPOE or both.

The integrated EHR with CDSS segment is anticipated to witness lucrative growth over the forecast period. Increasing awareness and adoption of EHR by multi-specialty health care units is poised to influence the growth of the integrated EHR with the CDSS segment. CDS systems, when integrated with EHR, provide patient database and history to CDSS, which can provide clinical solutions and suggest medication to the practitioner, thus automating the clinical workflow. CDSS and EHRs are often integrated to streamline workflows and make use of present data sets. There is an increasing number of CDSS functions that are built into EHR systems, which is expected to support segment growth.

Application Insights

Drug allergy alerts held the largest revenue share of over 25.0% in 2021. Several people have allergies to some specific drugs, and consequently, it is important to have systems that provide allergy alerts. The burden of allergies, i.e., drug allergies, is rising. In the process of prescribing, dispensing, or administering a drug, a medicine error may happen and can have adverse significance, e.g., medication may be given to a patient with a documented allergy to that drug.

The clinical guidelines segment is anticipated to witness lucrative growth over the forecast period. The CDS system offers guidelines for treatment and diagnosis. It retrieves data from the knowledge base and utilizes it for treatment, providing the practitioner with clinical guidelines to be followed during the treatment course, thus, improving the quality of care.

Component Insights

The services segment held the largest revenue share of over 40.0% in 2021. This is due to timely up-gradation of software as well as the knowledge base available for use. Services in CDSS involve the maintenance of components and their accessories. It includes hardware and software upgrades and provides a knowledge database with the latest innovations and recent medications.

The software segment is anticipated to witness lucrative growth over the forecast period. The CDSS software, when used in integration with software for CPOE and EHRs, provides enhanced decision support by making customized and specific results for the particular patient. Novel innovations for technical support and interoperability of the software are anticipated to drive the market over the forecast period.

Delivery Mode Insights

The on-premise systems segment captured the largest revenue share of over 40.0% in 2021. Cloud-based systems held the second-largest revenue share in 2021 owing to significant innovation in information technology, with potential applications in the healthcare sector. Reliability and cost-efficiency are major factors that contribute to the growth of this segment. The primary services provided under cloud computing are Platform as a Service (PaaS) which creates a platform, i.e., develops an OS to run the software, Infrastructure as a Service (IaaS) which uses virtual technology to create a user interface to provide the services, and Software as a Service (SaaS) which forms the most critical aspect of the cloud provider as it enables them to operate, install, and manage software to provide services to the end user.

Global clinical decision support systems market share, by delivery mode, 2021 (%)

CDSSs require access to healthcare data and knowledge, which is stored in a database. Data stored on the web is easily accessible through mobile and computer devices. Web-based devices use the data stored on the web to provide decision support to medical practitioners. Technology innovation has enabled the designing of web-based systems for the accurate diagnosis of different health conditions. For instance, Net Decision Support System is a web-based system that offers support for depression management.

Regional Insights

North America dominated the global CDSS market in 2021 with a revenue share of over 45.0%. This can be attributed to the surging demand for healthcare information technology solutions in the medical sector. Rapid technological advancements and the growing importance of providing quality healthcare services are further contributing to market growth in this region.

Asia Pacific is anticipated to be the fastest-growing regional market over the forecast period. This can be attributed to the increasing investments in the healthcare sector in countries such as Australia, China, India, and Japan. The Asia Pacific market is showing high potential due to increasing R&D expenditure by the governments of key economies for increasing the penetration of information technology in the medical field. In addition, the increasing geriatric population is likely to serve as a key factor fueling the Asia Pacific market.

Key Companies & Market Share Insights

The market is fairly competitive. The market has been characterized by the presence of most notable participants, along with other providers of clinical decision support systems. These players are involved in new product launches, product innovations, acquisitions, and partnerships to gain a competitive edge over each other.

For instance, in April 2021, Change Healthcare revealed InterQual 2021, the newest version of the corporation’s flagship CDS solution. This release features four innovative Medicare criteria elements along with a substantial amount of evidence-based content updates and enhancements, comprising new guidance for COVID-19 patients, addressing social factors of health, and suitable usage of telehealth. Moreover, in May 2020, DHIndia announced a partnership with [email protected] & HealtheLife to develop a CDSS for the screening of COVID-19. The partnership also included the formation of a minimal triage application for front-line doctors. Some prominent players in the global clinical decision support systems (CDSS) market include

  • McKesson Corporation

  • Cerner Corporation

  • Siemens Healthineers GmbH

  • Allscripts Healthcare, LLC

  • athenahealth, Inc.

  • NextGen Healthcare Inc.

  • Koninklijke Philips N.V. (Royal Philips)

  • IBM Corporation

  • Agfa-Gevaert Group

  • Wolters Kluwer N.V.

Clinical Decision Support Systems Market Report Scope

Report Attribute


The market size value in 2022

USD 4.86 billion

The revenue forecast in 2030

USD 10.7 billion

Growth Rate

CAGR of 10.4% from 2022 to 2030

Base year for estimation


Historical data

2017 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million/billion & CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, delivery mode, component, region

Regions covered

North America; Europe; Asia Pacific; Latin America; MEA

Country Scope

U.S.; Canada; U.K.; Germany; Italy; France; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; Israel

Key companies profiled

McKesson Corporation; Cerner Corporation; Siemens Healthineers GmbH; Allscripts Healthcare, LLC; athenahealth, Inc.; NextGen Healthcare Inc.; Koninklijke Philips N.V. (Royal Philips); IBM Corporation; Agfa-Gevaert Group; Wolters Kluwer N.V.

Customization scope

Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report 

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this report, Grand View Research has segmented the global clinical decision support systems (CDSS) market report based on product, application, delivery mode, component, and region:

  • Product Outlook (Revenue, USD Million, 2017 - 2030)

    • Standalone CDSS

    • Integrated CPOE with CDSS

    • Integrated E.H.R. with CDSS

    • Integrated CDSS with CPOE & E.H.R.

  • Application Outlook (Revenue, USD Million, 2017 - 2030)

    • Drug-drug Interactions

    • Drug Allergy Alerts

    • Clinical Reminders

    • Clinical Guidelines

    • Drug Dosing Support

    • Others

  • Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030)

    • Web-based Systems

    • Cloud-based Systems

    • On-premise Systems

  • Component Outlook (Revenue, USD Million, 2017 - 2030)

    • Hardware

    • Software

    • Services

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • India

      • Japan

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • MEA

      • South Africa

      • Saudi Arabia

      • Israel

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.